UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Samsung BioLogics to complete Biogen’s call option
by Lee Han-soo
2018-11-06 10:45
Will PharmAbcine be new force on KOSDAQ?
by Nam Doo-hyun
2018-11-05 16:32
Celltrion gets orders for Herzuma in France
by Lee Han-soo
2018-11-02 17:08
Government to help Pharmicell develop therapy for acute kidney injury
by Lee Han-soo
2018-11-02 14:16
SLS Bio registers patent for nanotechnology multiplex diagnostic in Europe
by Lee Han-soo
2018-11-01 11:03
라인
CrystalGenomics to change molecular targeted therapy from injection to oral drug in trials
by Nam Doo-hyun
2018-10-30 10:52
‘I will help make Korea original holder of anticancer drugs’
by So Jae-hyeon
2018-10-29 14:43
‘Bio Solution’s value to rise on arthritis cell therapy’
by Nam Doo-hyun
2018-10-25 16:30
Samsung BioLogics posts ₩101.1 billion in Q3 sales
by Lee Han-soo
2018-10-25 11:02
CancerRop advances into Malaysian gene market
by Lee Han-soo
2018-10-24 17:49
라인
Celltrion releases clinical trial results for Remsima SC in EU and US
by Lee Han-soo
2018-10-24 16:47
Will synthetic biology be vital in smart therapeutics?
by Nam Doo-hyun
2018-10-24 16:40
Biotech shares tank amid nosediving of Seoul stocks
by Nam Doo-hyun
2018-10-24 11:35
‘Antibody drug developer AbClon noteworthy’
by Nam Doo-hyun
2018-10-22 14:49
L&C BIO sets offering price at ₩24,000 for KOSDAQ debut
by So Jae-hyeon
2018-10-22 14:12
라인
'Superbug' fears bring antibiotics developers under spotlight
by Nam Doo-hyun
2018-10-22 11:53
Celltrion, Samsung BioLogics named Fortune’s ‘Future 50’
by Lee Han-soo
2018-10-19 16:34
CancerRop launches unit to develop cell therapies
by Lee Han-soo
2018-10-18 15:25
Biogen, Samsung Bioepis announce European launch of Imraldi
by Lee Han-soo
2018-10-17 17:28
Bio stocks listed under ‘tech exception policy’ perform better
by Nam Doo-hyun
2018-10-15 12:27
-
이전
11
12
13
14
15
16
17
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top